That discovery might provide a "window of opportunity" to develop a much-needed noninvasive approach to assessing the potential toxic effects of anesthetic agents on the brain in infants and children, according to the report by Dr. Richard J. Levy of Children's National Medical Center, Washington, D.C., and colleagues.
Retinal Apoptosis May Reflect Neurotoxic Effects of AnesthesiaThe researchers performed a series of experiments to determine whether isoflurane induces apoptosis in the developing retina—a lining of light-sensitive tissue inside the eye that transmits visual information to the brain. Apoptosis is a "widespread and natural phenomenon" in the development of the central nervous system. This process might make the developing brain more vulnerable to the potential neurotoxic effects of anesthetic agents.
In the study, one-week-old mice were studied after brief exposure to the inhalant anesthetic isoflurane. Indicators of apoptosis in retinal cells were compared for isoflurane-exposed mouse pups versus animals exposed to air only.
The results showed increases in several different markers of apoptosis in the retinas of isoflurane-exposed mice. The patterns of apoptosis marker expression provided clues as to the pathways causing programmed cell death, including variations between different layers of the retina.
Some types of cells were strongly affected while others were relatively spared—differences that might be related to the timing of normal apoptosis. For example, Dr. Levy and colleagues note that light-sensitive photoreceptor cells within the retina showed no signs of anesthesia-induced apoptosis. This finding that "may indicate some level of protection" and may provide clues to developing new treatment approaches.
Why study the effects of anesthesia on retinal cells in mice? Common anesthetics induce widespread apoptosis of neurons (nerve cells) in the developing brain of mammals. In human infants and young children, exposure to anesthesia for unavoidable surgical procedures has been linked to the development of cognitive (intellectual) and behavioral disorders.
But so far, there's no evidence to confirm—or refute—that anesthetics cause neurotoxic effects in children. The International Anesthesia Research Society (IARS), in partnership with the US Food and Drug Administration, has launched a research initiative called SmartTots to address the critical public health issues associated with the safe use of anesthesia and sedatives in young children. "The retina is unique in that it is the only portion of the central nervous system that can be directly visualized noninvasively," Dr. Levy and coauthors write. Methods evaluating the retina might, for the first time, provide a directly observable approach to assessing the effects of anesthetic agents on neural cells. One dye used in the study bound to cells undergoing apoptosis, providing a potential opportunity to visualize the process of programmed cell death in the developing retina The researchers note that many important issues remain to be clarified by further research—especially the correspondence between anesthetic damage to the brain in mouse pups versus human children. Another key issue is whether the retinal cell apoptosis truly reflects anesthesia-induced damage occurring in the brain. "Ultimately," Dr. Levy and colleagues conclude, "we may be able to develop a noninvasive imaging modality to determine whether anesthesia-induced neuronal apoptosis occurs in infants and children."
Anesthesia & Analgesia is published by Wolters Kluwer.
Read the article in Anesthesia & Analgesia.
About Anesthesia & AnalgesiaAnesthesia & Analgesia was founded in 1922 and was issued bi-monthly until 1980, when it became a monthly publication. A&A is the leading journal for anesthesia clinicians and researchers and includes more than 500 articles annually in all areas related to anesthesia and analgesia, such as cardiovascular anesthesiology, patient safety, anesthetic pharmacology, and pain management. The journal is published on behalf of the IARS by Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health.
About the IARSThe International Anesthesia Research Society is a nonpolitical, not-for-profit medical society founded in 1922 to advance and support scientific research and education related to anesthesia, and to improve patient care through basic research. The IARS contributes nearly $1 million annually to fund anesthesia research; provides a forum for anesthesiology leaders to share information and ideas; maintains a worldwide membership of more than 15,000 physicians, physician residents, and others with doctoral degrees, as well as health professionals in anesthesia related practice; sponsors the SmartTots initiative in partnership with the FDA; supports the resident education initiative OpenAnesthesia; and publishes two journals, Anesthesia & Analgesia and A&A Case Reports.
About Wolters KluwerWolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
RSS